US 12,290,434 B2
Prosthetic capsular devices, systems, and methods
Gary N. Wortz, Nicholasville, KY (US); and Rick William Ifland, Versailles, KY (US)
Assigned to Omega Ophthalmics LLC, Versailles, KY (US)
Filed by Omega Ophthalmics LLC, Versailles, KY (US)
Filed on Apr. 17, 2023, as Appl. No. 18/301,569.
Application 18/301,569 is a continuation of application No. 17/124,290, filed on Dec. 16, 2020, granted, now 11,654,016.
Application 17/124,290 is a continuation of application No. 16/128,233, filed on Sep. 11, 2018, granted, now 10,898,315, issued on Jan. 26, 2021.
Application 16/128,233 is a continuation of application No. 15/789,555, filed on Oct. 20, 2017, granted, now 10,111,746, issued on Oct. 30, 2018.
Claims priority of provisional application 62/500,932, filed on May 3, 2017.
Claims priority of provisional application 62/461,675, filed on Feb. 21, 2017.
Claims priority of provisional application 62/421,929, filed on Nov. 14, 2016.
Claims priority of provisional application 62/411,129, filed on Oct. 21, 2016.
Prior Publication US 2024/0081976 A1, Mar. 14, 2024
Int. Cl. A61F 2/16 (2006.01); A61F 2/14 (2006.01)
CPC A61F 2/1613 (2013.01) [A61F 2/15 (2015.04); A61F 2/1601 (2015.04); A61F 2/1618 (2013.01); A61F 2/1624 (2013.01); A61F 2/1648 (2013.01); A61F 2/1694 (2013.01); A61F 2/1627 (2013.01); A61F 2002/1681 (2013.01); A61F 2002/16901 (2015.04)] 20 Claims
OG exemplary drawing
 
1. A prosthetic capsular device configured to be inserted in a natural capsular bag of an eye after removal of a lens, the device comprising:
a housing structure capable of containing a drug eluting device, the housing structure comprising:
an anterior portion comprising:
an anterior opening, wherein the anterior opening is capable of allowing at least one of insertion, removal, or replacement of the drug eluting device, wherein the anterior opening is surrounded by an anterior wall defining a first capsular-engaging surface, and
an anterior lateral sidewall extending from the anterior opening;
a posterior portion comprising:
a posterior opening, wherein the posterior opening is capable of allowing at least one of insertion, removal, or replacement of the drug eluting device, and wherein the posterior opening is surrounded by a posterior wall defining a second capsular-engaging surface, and
a posterior lateral sidewall extending from the posterior opening; and
a lateral portion interposed between the anterior portion and the posterior portion, wherein the lateral portion comprises a central lateral sidewall that protrudes radially beyond the anterior lateral sidewall and the posterior lateral sidewall,
wherein the anterior lateral sidewall, central lateral sidewall, and posterior lateral sidewall form a lateral side of the housing structure,
wherein the central lateral sidewall comprises an exterior surface comprising a rounded bulge, the rounded bulge extending radially beyond the anterior lateral sidewall and the posterior lateral sidewall, and
wherein the central lateral sidewall comprises an interior surface comprising the structure.